Clinical trial

PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)

NCT03327740

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-09-30

PhaseN/A

Study timeline

Study start (actual)2014-09-30Date precision: day

Registry last updated2020-02-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Infection, Human Immunodeficiency Virus Iunresolved

Interventions

DTG based ARV regimen with ABCDRUG

DTG based ARV regimen without ABCDRUG

RAL or EGV based ARV regimens with ABCDRUG

RAL or EGV based regimens without ABCDRUG

Any other DTG based ARV regimen as monotherapyDRUG

Sponsors & collaborators

ViiV Healthcarelead sponsor

GlaxoSmithKlinecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03327740 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.